ZAXOPAM Drug Patent Profile
✉ Email this page to a colleague
When do Zaxopam patents expire, and what generic alternatives are available?
Zaxopam is a drug marketed by Quantum Pharmics and is included in three NDAs.
The generic ingredient in ZAXOPAM is oxazepam. There are eight drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the oxazepam profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Zaxopam
A generic version of ZAXOPAM was approved as oxazepam by UNITED RES LABS on August 10th, 1987.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ZAXOPAM?
- What are the global sales for ZAXOPAM?
- What is Average Wholesale Price for ZAXOPAM?
Summary for ZAXOPAM
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 3 |
| Raw Ingredient (Bulk) Api Vendors: | 43 |
| Patent Applications: | 4,210 |
| DailyMed Link: | ZAXOPAM at DailyMed |
US Patents and Regulatory Information for ZAXOPAM
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Quantum Pharmics | ZAXOPAM | oxazepam | CAPSULE;ORAL | 070650-001 | Mar 1, 1988 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Quantum Pharmics | ZAXOPAM | oxazepam | CAPSULE;ORAL | 070640-001 | Mar 1, 1988 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Quantum Pharmics | ZAXOPAM | oxazepam | CAPSULE;ORAL | 070641-001 | Mar 1, 1988 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
